Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative proteomic analysis of cerebrospinal fluid and brain tissue using Orbitrap Astral and timsTOF Pro 2 platforms with data-independent acquisition.

Diagnosis (Berlin, Germany)·2026
Same author

The molecular glue CLEO4-88 inhibits the ACAA1 thiolase by induced binding to GID4.

Nature chemical biology·2026
Same author

Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer's disease: correlation with other biomarkers.

Clinical proteomics·2026
Same author

LncRNA CISTR-ACT regulates cell size in human and mouse by guiding FOSL2.

Nature communications·2025
Same author

Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors.

The EMBO journal·2025
Same author

tRNA-overlapping long non-coding RNA loci repress codon-biased genes.

Cell reports·2025

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Miyo K Chatanaka1, Cassandra J Wong2, Antoninus Soosaipillai3

  • 1University of Toronto, Toronto, ON, Canada.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
PubMed
Summary

We developed a sensitive mass spectrometry method to identify autoantibodies in cerebrospinal fluid (CSF) for Alzheimer's disease (AD) research. This technique improves detection limits for neural autoantibodies, aiding in understanding AD autoimmune pathogenesis.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Neuroimmunology
  • Proteomics
  • Mass Spectrometry

Background:

  • Alzheimer's disease (AD) research increasingly explores the autoimmune hypothesis, suggesting neuronal damage from autoantibodies.
  • Developing sensitive and specific methods is crucial for identifying these autoantibodies against neuronal proteins.

Purpose of the Study:

  • To optimize and validate a method for unbiased autoantibody identification in human cerebrospinal fluid (CSF).
  • To establish a reliable assay for detecting autoantibodies potentially involved in AD pathogenesis.

Main Methods:

  • A method involving immunoglobulin capture, antigen binding, enzymatic digestion, and mass spectrometry (MS) was employed.
  • Optimization utilized CSF spiked with a known monoclonal antibody (KLK6ab), analyzed on Orbitrap Astral and Bruker timsTOF Pro 2 platforms using data-independent acquisition (DIA).

Main Results:

  • The optimized method achieved a limit of detection of 0.2ng for KLK6ab, a significant improvement over previous data-dependent acquisition (DDA) methods (5ng).
  • Shotgun proteomics identified 1988 proteins on one MS platform and 1241 on another, demonstrating broad proteome coverage.

Conclusions:

  • The validated method, incorporating an internal antibody control, ensures reliable performance across different mass spectrometry platforms.
  • This assay is poised to be instrumental in discovering novel autoantibodies linked to Alzheimer's disease.